跳至主要内容
临床试验/NCT05496439
NCT05496439已完成不适用

Study of the Prognosis of Patients With Heart Failure With Preserved Ejection Fraction

Chongqing Medical University1 个研究点 分布在 1 个国家目标入组 172 人开始时间: 2020年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
172
试验地点
1
主要终点
death

研究概览

简要总结

Study of the prognosis of patients with heart failure with preserved ejection fraction

详细描述

Obesity is an independent risk factor for heart failure with preserved ejection fraction (HFpEF), however, the impact of visceral fat area (VFA) in patients with HFpEF is unclear. According to established process of patients' selection, a total of 172 patients whose mean age was 72 years were included in this study, and the median follow-up duration was 395.5 days(interquartile range: 207.5 to 535.5 days). All patients were divided into two groups based on the best cut-off value of VFA, and the primary outcome of this study was all-cause death in patients with HFpEF. The aim of this study was to clarify whether VFA has prognostic value in patients with HFpEF by Kaplan-Meier analysis and cox analysis.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult aged >=18years old;
  • Diagnosed with HFpEF.Diagnostic criteria including:
  • 1)left ventricular ejection fraction ≥50%; 2)with the symptoms and/or signs of heart failure; 3)BNP≥35 pg/mL and/or NTproBNP≥125 pg/mL; 4)at least one additional criterion: relevant structural heart disease(LVH and/or LAE) or diastolic dysfunction

排除标准

  • Age <18 years old;
  • LVEF less than 45% at any time;
  • cancer diagnosis.

结局指标

主要结局

death

时间窗: The median follow-up time of 395.5 days(interquartile range: 207.5 to 535.5 days)

all-cause death

次要结局

未报告次要终点

研究者

发起方
Chongqing Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dongying Zhang

clinical professor

Chongqing Medical University

研究点 (1)

Loading locations...

相似试验

Study of the Prognosis of Patients With Heart... | 临床试验